Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Claxton, David F  [Clear All Filters]
2014
Abbi KKS, Rybka W, W Ehmann C, Claxton DF. Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia. Clin Lymphoma Myeloma Leuk. 2014.
2015
Robuccio A, Ssentongo P, Sather MD, Claxton DF, Gilliam FG. Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy. Epilepsy Behav Case Rep. 2015;4:48-51.
2016
Liu Q, Chen L, Atkinson JM, Claxton DF, Wang H-G. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model. Cell Death Dis. 2016;7(9):e2361.
2023
Qian F, Nettleford SK, Zhou J, Arner BE, Hall MA, Sharma A, Annageldiyev C, Rossi RM, Tukaramrao DB, Sarkar D, et al. Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells. Cell Rep. 2023;42(7):112794.
Jia B, Zhao C, Minagawa K, Shike H, Claxton DF, W Ehmann C, Rybka WB, Mineishi S, Wang M, Schell TD, et al. Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model. J Immunol. 2023.
2024
Brow D, Shike H, Kendrick J, Pettersson L, Mineishi S, Claxton DF, Wirk B, Cioccio J, Greiner RJ, Viswanatha D, et al. Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods. Hum Immunol. 2024:110794.